RR

Rajesh Ramesh Jain

Active Director Designated Partner DIN 10922268
DIN 10922268 First appointment Jan 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajesh Ramesh Jain

Data last updated:

Rajesh Ramesh Jain is a Designated Partner at Vratam Pharma Llp (since 2025).

DIN 10922268
Primary Designation Designated Partner
First Appointment 24 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner24 Jan 20252025Active

Board colleagues of Rajesh Ramesh Jain

NameDINCompanyDesignation
Mohandas Raghunath Dhake10922269Vratam Pharma LlpDesignated Partner
Shah Ankit Pramod08461291Vratam Pharma LlpDesignated Partner
Tejas Dattatray Kalkar08461290Vratam Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Vratam Pharma Llp
Premium access

Shareholding and investment profile for Rajesh Ramesh Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Ramesh Jain

Rajesh Ramesh Jain currently holds 1 directorship: Vratam Pharma Llp (Designated Partner, since 24 Jan 2025).

Rajesh Ramesh Jain was first appointed on 24 Jan 2025 as Designated Partner at Vratam Pharma Llp.

The current boards of Rajesh Ramesh Jain's companies include Mohandas Raghunath Dhake (Vratam Pharma Llp), Shah Ankit Pramod (Vratam Pharma Llp), Tejas Dattatray Kalkar (Vratam Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available